|
David G. Lott MD
Associate Director, Center for Regenerative Biotherapeutics
Mayo Clinic
USA
|
David G. Lott, M.D. holds the academic rank of Professor of Otolaryngology at Mayo Clinic College of Medicine and Science. He serves as the Chair of the Division of Laryngology at the Mayo Clinic in Arizona. His practice includes voice and swallowing restoration, laryngeal cancer, and laryngotracheal reconstruction.
Dr. Lott received his M.D. degree at the University of Iowa Carver College of Medicine and completed a residency in Otolaryngology/Head and Neck Surgery at the Cleveland Clinic Head and Neck Institute. He received further fellowship training in Laryngeal Surgery and Professional Voice at Harvard Medical School/Massachusetts General Hospital.
Dr. Lott is the Associate Director of the Mayo Clinic Center for Regenerative Biotherapeutics. He is faculty for both the Clinical & Translational Science and Regenerative Sciences tracks within the Mayo Clinic Graduate School of Biomedical Sciences.
In addition, he is the Director of the Head and Neck Regenerative Medicine Lab at Mayo Clinic. The primary goal of the lab is to establish safe and effective clinical translation of regenerative medicine technology. The lab is initiating a FDA-approved human clinical trial to evaluate the efficacy of the tissue-engineered technologies. Additionally, the efforts of this program have established the world’s first UNOS-approved Larynx and Trachea Transplantation Program.
Dr. Lott has authored many publications on laryngeal regenerative techniques, including invited manuscripts on laryngeal transplantation and book chapters on laryngeal transplantation and larynx bioengineering. He has also given multiple presentations on the topic at various national and international professional meetings. Additionally, he co-authored the book, “Contemporary Transoral Surgery for Primary Head and Neck Cancer”.
Throughout his career Dr. Lott has received many awards and honors, including being named in the Top Voice Doctors in America by Billboard Magazine. He received the Transform the Practice Award conferred by Mayo Clinic. Additionally, he has been honored with the Mayo Clinic Teacher of the Year Award and the Distinguished Clinician Award.
Dr. Lott received his M.D. degree at the University of Iowa Carver College of Medicine and completed a residency in Otolaryngology/Head and Neck Surgery at the Cleveland Clinic Head and Neck Institute. He received further fellowship training in Laryngeal Surgery and Professional Voice at Harvard Medical School/Massachusetts General Hospital.
Dr. Lott is the Associate Director of the Mayo Clinic Center for Regenerative Biotherapeutics. He is faculty for both the Clinical & Translational Science and Regenerative Sciences tracks within the Mayo Clinic Graduate School of Biomedical Sciences.
In addition, he is the Director of the Head and Neck Regenerative Medicine Lab at Mayo Clinic. The primary goal of the lab is to establish safe and effective clinical translation of regenerative medicine technology. The lab is initiating a FDA-approved human clinical trial to evaluate the efficacy of the tissue-engineered technologies. Additionally, the efforts of this program have established the world’s first UNOS-approved Larynx and Trachea Transplantation Program.
Dr. Lott has authored many publications on laryngeal regenerative techniques, including invited manuscripts on laryngeal transplantation and book chapters on laryngeal transplantation and larynx bioengineering. He has also given multiple presentations on the topic at various national and international professional meetings. Additionally, he co-authored the book, “Contemporary Transoral Surgery for Primary Head and Neck Cancer”.
Throughout his career Dr. Lott has received many awards and honors, including being named in the Top Voice Doctors in America by Billboard Magazine. He received the Transform the Practice Award conferred by Mayo Clinic. Additionally, he has been honored with the Mayo Clinic Teacher of the Year Award and the Distinguished Clinician Award.